Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (5234)	1/3/1998 6:59:00 AM
From: opalapril	Read Replies (2) \| Respond to of 17367

George, Robert and all: Not that we need more boards in the gathering clutter, but I stumbled across this -- messages.yahoo.com@m2.yahoo.com Hope the link works for you but in case it doesn't ...... Yahoo! has initiated message boards. The linked message reports on what the poster describes as an "online discussion" with M. Murphy. Site undisclosed. P3 for Neuprex is described. Also, Murphy is quoted as saying he's adding to XOMA position, things are going well, company will apply for NDA in late '98 and turn profitable in '99.

To: Robert K. who wrote (5234)	1/3/1998 10:21:00 AM
From: aknahow	Respond to of 17367

Bob, perhaps, just perhaps, I am thinking that if the market paid no attention to the start of P III the first time that when Xoma once again announces that it is in P III for Trauma some will now pay attention.<g> In fact, before your post about this subject I had e-mailed Ellen twice about it at two different addresses. Felt it was minor but still important enough to require quick correction. Indeed believed that my teasing you about it would keep the issue alive and help XOMA realize its got to be corrected. You see it is possible the have already printed up x thousands of hard copies and perhaps even mailed them out creating a small internal debate about the cost of correcting this error. BTW appreciate your estimate of the $4 to $6 million from gne but thought payments were based on milestones and am intested in which milestone generated the payment.